Press Releases

National Brain Tumor Society Marks the Signing of the Honoring Our PACT Act Today, National Brain Tumor Society (NBTS) Chief Executive Officer, David Arons, attended the White House ceremony for the signing of the Honoring Our PACT Act by President Joe Biden. Ahead of the signing, Mr. Arons released the following statement on behalf of NBTS: “National Brain Tumor Society supports enactment of the PACT Act and applauds […] August 10, 2022

National Brain Tumor Society Grant Seeks to Establish New Pipeline of Promising Meningioma Treatments Two highly experienced teams will work together to advance new drugs for the most common type of brain tumor Today, the National Brain Tumor Society (NBTS) announced a $400,000 grant to Drs. Priscilla K. Brastianos, Director, Central Nervous System Metastasis Center, Mass General Cancer Center (MGH), and Associate Professor of Medicine at Harvard Medical School, and Rachael […] May 30, 2022

National Brain Tumor Society (NBTS) Statement on 2023 Notice of Benefits and Payment Parameters Final Rule Yesterday, the Department of Health and Human Services (HHS) released its 2023 Notice of Benefits and Payment Parameters (NBPP) Final Rule (final 2023 Payment Notice) for Marketplace plans operating on the Federally-Facilitated Exchanges (FFEs), state-based exchanges (SBEs), and state-based exchanges operating on the federal platform (SBE-FPs) in 2023. The following is a statement from David […] April 29, 2022

National Brain Tumor Society (NBTS) Statement on 2022 Glioblastoma Awareness Day Resolution in U.S. Congress For the fourth straight year, the National Brain Tumor Society (NBTS) is championing a bipartisan, bicameral resolution designating a national Glioblastoma (GBM) Awareness Day in July. This year’s resolution seeks to commemorate GBM Awareness Day on July 20 to raise public awareness for this highly aggressive and deadly form of brain cancer. In the Senate, […] April 13, 2022

National Brain Tumor Society Grant Will Test Drugs That Target a Tumor’s Metabolism Today, the National Brain Tumor Society (NBTS) announced a $350,000 grant to Dr. Paul Mischel, Professor and Vice Chair for Research, Department of Pathology, and Institute Scholar, ChEM-H, Stanford University, to advance new approaches to targeting the metabolism of glioblastoma (GBM) brain tumors. “Dr. Mischel made a number of critical discoveries as part of the […] April 5, 2022